Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

Clinical trial NCT06712017 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06712017
Sponsor: GrandPharma (China) Co., Ltd.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma Non-Resectable

Start date: 2024-08-22
Primary completion: 2024-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.